The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units

References

• Global Initiative for Chronic Obstructive Lung Disease [webpage on the Internet]Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2015 Available from: http://www.goldcopd.org/Accessed June 24, 2015
   Google Scholar
• AgustiACalverleyPMCelliBEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigatorsCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar
• KimVHanMKVanceGBCOPDGene InvestigatorsThe chronic bronchitic phenotype of COPD: an analysis of the COPDGene StudyChest2011140362663321474571
   PubMed Web of Science ®Google Scholar
• de OcaMMHalbertRJLopezMVThe chronic bronchitis phenotype in subjects with and without COPD: the PLATINO studyEur Respir J2012401283622282547
   PubMed Web of Science ®Google Scholar
• SundhJJohanssonGLarssonKComorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care unitsInt J Chron Obstruct Pulmon Dis20151017318325653516
   PubMed Web of Science ®Google Scholar
• Ekberg-AronssonMPehrssonKNilssonJANilssonPMLöfdahlCGMortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitisRespir Res200569816120227
   PubMed Web of Science ®Google Scholar
• LindbergASawalhaSHedmanLLarssonLGLundbäckBRönmarkESubjects with COPD and productive cough have an increased risk for exacerbations and deathRespir Med20151091889525528948
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• OostenbrinkJBRutten-van MölkenMPResource use and risk factors in high-cost exacerbations of COPDRespir Med200498988389115338802
   PubMed Web of Science ®Google Scholar
• NishimuraKSatoSTsukinoMEffect of exacerbations on health status in subjects with chronic obstructive pulmonary diseaseHealth Qual Life Outcomes200976919624834
   PubMed Web of Science ®Google Scholar
• BourbeauJFordGZackonHPinskyNLeeJRubertoGImpact on patients’ health status following early identification of a COPD exacerbationEur Respir J200730590791317715163
   PubMed Web of Science ®Google Scholar
• GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMA new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)Prim Care Respir J201322111712123443227
   PubMedGoogle Scholar
• PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775776423152680
   PubMed Web of Science ®Google Scholar
• RennardSICalverleyPMGoehringUMBredenbrökerDMartinezFJReduction of exacerbations by the PDE4 inhibitor roflumilast – the importance of defining different subsets of patients with COPDRespir Res2011121821272339
   PubMed Web of Science ®Google Scholar
• MartinezFJCalverleyPMGoehringUMBroseMFabbriLMRabeKFEffect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialLancet2015385997185786625684586
   PubMed Web of Science ®Google Scholar
• SundhJStällbergBLisspersKMontgomerySMJansonCCo-morbidity, body mass index and quality of life in COPD using the Clinical COPD QuestionnaireCOPD20118317318121513436
   PubMedGoogle Scholar
• KruisALStällbergBJonesRCPrimary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation studyPLoS One201493e9014524598945
   PubMed Web of Science ®Google Scholar
• SeymourJMSpruitMAHopkinsonNSThe prevalence of quadriceps weakness in COPD and the relationship with disease severityEur Respir J2010361818819897554
   PubMed Web of Science ®Google Scholar
• MaltaisFDecramerMCasaburiRATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPDAn official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20141899e15e6224787074
   PubMed Web of Science ®Google Scholar
• PatelARHurstJRExtrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the artExpert Rev Respir Med20115564766221955235
   PubMed Web of Science ®Google Scholar
• SpäteUSchulzePCProinflammatory cytokines and skeletal muscleCurr Opin Clin Nutr Metab Care20047326526915075917
   PubMed Web of Science ®Google Scholar
• WatzHWaschkiBBoehmeCClaussenMMeyerTMagnussenHExtrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional studyAm J Respir Crit Care Med2008177774375118048807
   PubMed Web of Science ®Google Scholar
• YendeSWatererGWTolleyEAInflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsThorax2006611101616284220
   PubMed Web of Science ®Google Scholar
• WüstRCMorseCIde HaanARittwegerJJonesDADegensHSkeletal muscle properties and fatigue resistance in relation to smoking historyEur J Appl Physiol2008104110311018560879
   PubMed Web of Science ®Google Scholar
• SilvermanEKWeissSTDrazenJMGender-related differences in severe, early-onset chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016262152215811112130
   PubMed Web of Science ®Google Scholar
• Van WinkleLSGundersonADShimizuJABakerGLBrownCDGender differences in naphthalene metabolism and naphthalene-induced acute lung injuryAm J Physiol Lung Cell Mol Physiol20022825L1122L113411943679
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• BurgelPRNesme-MeyerPChanezPInitiatives Bronchopneumopathie Chronique Obstructive Scientific CommitteeCough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjectsChest2009135497598219017866
   PubMed Web of Science ®Google Scholar
• HerathSCPoolePProphylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD) [review]Cochrane Database Syst Rev201311CD00976424288145
   PubMed Web of Science ®Google Scholar